Browse diseases

…Objectives To characterize systemic lupus erythematosus (SLE) patients with Hemophagocytic lymphohistiocytosis (HLH) in…

…Objectives Systemic lupus erythematosus (SLE) and systemic sclerosis (SSc) are distinct connective tiss…

…ations.Conclusions This case highlights the fulminant course of pulmonary-renal syndrome in SLE and the importance of early diagnosis and multimodal imm…

…ed outcomes (PROs) have been less extensively evaluated.Methods Systemic lupus erythematosus patients from a single-center prevalent cohort were included. T…

…linically required glucocorticoid (GC) therapy in patients with systemic lupus erythematosus (SLE).Methods The study included 436 SLE patients (87.6% women,…

…Objectives The timing of biologic initiation in systemic lupus erythematosus (SLE) may reflect disease phenotype and treatment strategy. We …

…Objectives Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with heterogeneous manife…

…ves To define a fit-for-purpose clinical outcome assessment for lupus arthritis, with thresholds for entry and improvement, which will form par…

… lupus serositis. First, the domain definition and scope in the SLE clinical trial context were defined. Potentially suitable measu…

…ly meaningful thresholds for entry and improvement, to classify haemolytic anaemia treatment response in a novel multi-domain outcome measure for …

…ous domain of a novel multi-domain clinical outcome measure for systemic lupus erythematosus (SLE) clinical trials, the Treatment Response Measure for SLE (…

…s (NLR, MLR, PLR, SII, SIRI, AISI) were significantly higher in SLE than in HC (P<0.001). In multivariable linear models, higher C-…